Literature DB >> 8597485

Regulation of human dehydroepiandrosterone metabolism by insulin.

J E Nestler1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8597485     DOI: 10.1111/j.1749-6632.1995.tb17373.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women.

Authors:  S Savastano; A Belfiore; B Guida; L Angrisani; F Orio; T Cascella; F Milone; F Micanti; G Saldalamacchia; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

Review 2.  Dehydroepiandrosterone and diseases of aging.

Authors:  R R Watson; A Huls; M Araghinikuam; S Chung
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

Review 3.  Endocrine changes (beyond diabetes) after bariatric surgery in adult life.

Authors:  S Savastano; C Di Somma; R Pivonello; G Tarantino; F Orio; V Nedi; A Colao
Journal:  J Endocrinol Invest       Date:  2013-02-27       Impact factor: 4.256

4.  Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S).

Authors:  S Savastano; R Valentino; A Belfiore; N De Luca; A de Alteriis; F Orio; S Palomba; A M Villani; C Falconi; G Lupoli; G Lombardi; C Falcone
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

5.  Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the Rotterdam Study.

Authors:  Adela Brahimaj; Taulant Muka; Maryam Kavousi; Joop S E Laven; Abbas Dehghan; Oscar H Franco
Journal:  Diabetologia       Date:  2016-10-22       Impact factor: 10.122

6.  Short-time intensive insulin therapy upregulates 3 beta- and 17 beta-hydroxysteroid dehydrogenase levels in men with newly diagnosed T2DM.

Authors:  Yun Hu; Ying Wang; Ting-Ting Cai; Lu Liu; Dong-Mei Li; Jian-Hua Ma; Bo Ding
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-19       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.